重新思考与年龄相关的黄斑退化临床试验:基于人工智能的OCT分析如何支持成功的结果?
Marie Louise Enzendorfer1, Merle Tratnig-Frankl1, Anna Eidenberger1
1Laboratory for Ophthalmic Image Analysis, Department of Ophthalmology and Optometry, Medical University of Vienna, 1090 Vienna, Austria.
Pharmaceuticals (Basel, Switzerland)
|March 27, 2025
概括
人工智能 (AI) 可以增强与年龄相关的黄斑变性 (AMD) 的临床试验. 人工智能提供了识别生物标志物和分层患者的新方法,改善了对新血管AMD (nAMD) 和地理缩 (GA) 的治疗评估.
科学领域:
- 眼科医生 眼科 眼科
- 生物医学工程 生物医学工程
- 临床试验设计 临床试验设计
背景情况:
- 与年龄相关的黄斑变性 (AMD) 是视力丧失的主要原因,由于人口老龄化,其患病率越来越高.
- 新血管AMD (nAMD) 和地理缩 (GA) 在临床试验中存在挑战,原因是进展和治疗反应的变化.
- 当前的试验终点可能无法充分捕捉微妙的治疗益处,特别是在GA.
研究的目的:
- 审查人工智能在分析光学连贯性断层扫描 (OCT) 对于AMD临床试验中的应用.
- 突出AI在优化试验设计和nAMD和GA的结果方面的潜力.
- 探索AI在识别新生物标志物和改善患者分层方面的作用.
主要方法:
- 关于人工智能在海外国家和地区对AMD分析中的应用现有文献的综述.
- 分析AI在患者分层和终点开发方面的潜力.
- 讨论AI对nAMD和GA临床试验设计的影响.
主要成果:
- 人工智能可以从OCT数据中识别新的,特定条件的生物标志物和终点.
- 人工智能有助于精确的患者分层,可能改善试验招募和统计能力.
- 用人工智能驱动的OCT分析为评估AMD治疗疗效提供了一种变革性的方法.
结论:
- 人工智能对优化与年龄相关的黄斑变性临床试验具有重大前景.
- 基于AI的OCT分析可以解决nAMD和GA的传统试验设计的局限性.
- 整合人工智能对于推动AMD治疗发展至关重要.
更多相关视频
10:14Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
3.0K
05:14Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
Published on: August 11, 2023
987
相关概念视频
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...